Compare SOLAI Limited (SLAI) vs Zoetis Inc (ZTS) Price & Performance

SOLAI LimitedTrade

Zoetis IncTrade

Price performance (Past 24H)

Key statistics

SOLAI Limited vs Zoetis Inc — how do they compare? SOLAI Limited trades at $3.72 (market cap $16.69M), while Zoetis Inc trades at $76.07 (market cap $31.95B). The key difference: Zoetis Inc is far larger — about 1914.3× SOLAI Limited's market cap, and Zoetis Inc pays a 2.78% dividend while SOLAI Limited pays none. Which is the better fit depends on your goals.

	SLAI	ZTS
Market Cap	$16.69M	$31.95B
Sector	Technology	Health
52-Week High	$26.74	$156.76
52-Week Low	$2.74	$71.91
Enterprise Value	$16.33M	$39.24B
Dividend Yield	—	2.78%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SLAI

SOLAI Limited to be delisted from NYSE due to low market cap, plans OTC market listing.PRNewsWire · 16 hours agoBearish View details →

ZTS

Class action lawsuits filed against CALX, AVAV, ZTS, and LCID over alleged misleading statements.GlobeNewsWire · 4 days agoBearish View details →

About SOLAI Limited

SOLAI focuses on providing innovative AI-driven software solutions. The company leverages artificial intelligence to enhance digital experiences and optimize business processes for various industries.

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.